Table 3.
Diagnostic accuracy of the quantitative assessment of regional cerebral atrophy including MR-planimetry, -volumetry, and automated methods for quantitative MRI analysis for the diagnosis of APD
References | Cohort size | Magnetic field | Main results | Discriminator | Accuracy, % |
---|---|---|---|---|---|
Schulz et al. (1999) | MSA-P 12/MSA-C 17/PD 11/PSP 6/HC 16 | 1.5 T | ↓ Mean striatal and brainstem volumes in MSA-P, MSA-C, and PSP ↓ Cerebellar volume in MSA-C and MSA-P Volumes were TIV-corrected Patients with PD could not be separated from HC and patients with MSA-P could not be separated from patients with PSP |
Discriminant function including volumes of brainstem, caudate nucleus, putamen, and cerebellum (stepwise linear discrimination)a | Overall correct classification 65% 91% of APD and 89% of non-APD classified correctly 75% of PD, 36% of HC, 67% of MSA-P, 76% of MSA-C and 50% of PSP classified correctly |
Se 76 (MSA-C) Sp 100 (vs. PD), 82 (vs. HC), 100 (vs. PSP) | |||||
Cordato et al. (2002) | PSP 21/PD 17/HC 23 | 1.5 T | ↑ Ventricular volume, ↓ whole brain and frontal GM volumes in PSP vs. PD and HC | Frontal GM volume | Se 95 (PSP) Sp 91 (vs. other groups) |
Groschel et al. (2004) | PSP 33/CBS 18/HC 22 (including 8 PSP and 7 CBD with a post-mortem confirmed diagnosis) | ↓ Brainstem volume (>midbrain) in PSP vs. CBS and HC ↓ Parietal and occipital lobes volumes (>white matter) in CBS vs. PSP and HC ↓ Area of CC in CBS vs. PSP and HC Volumes were TIV-corrected |
Discriminant function including midbrain, parietal WM, temporal GM, brainstem, frontal WM, and pons volumes | Overall correct classification 84% 95% of HC, 76% of CBS, 83% of PSP classified correctly |
|
Paviour et al. (2005) | PSP 19/MSA 10/PD 12/HC 12 | 1.5 T | ↓ SCP volume in PSP vs. MSA, PD, and HC Volumes were TIV-corrected |
SCP volume | Se 74 (PSP) Sp 77 (vs. other groups) |
Paviour et al. (2006b) | MSA-P 9/PSP 18/PD 9/HC 18 | 1.5 T | ↓ Midbrain and SCP volumes in PSP compared to MSA-P, PD and HC ↓ Frontal volume in PSP compared to PD and HC, but not to MSA-P Significant greater third ventricle in PSP compared to HC, but not to MSA-P and PD ↓ Cerebellar, pontine, and posterior inferior volumes in MSA-P compared to PD and HC ↓ Midbrain volume in MSA-P compared to HC No significant differences between PD and HC |
Midbrain, SCP, frontal, third ventricle, and whole brain volumes | Se 89 (PSP)b
Sp 97 (vs. MSA-P, PD, and HC) |
SCP, midbrain, pons, and cerebellar volumes | Se 94 (PSP)b
Sp 89 (vs. MSA-P) |
||||
Cosottini et al. (2007) | PSP 15/MSA-P 7/HC 14 | 1.5 T | ↓ md in PSP vs. HC, but is not significantly different between PSP and MSA-p patients ↓ ma in PSP vs. MSA-P and HC ↓ Midbrain volume in PSP patients vs. HC, but does not differ with respect to MSA-P ↓ pa in MSA-P vs. PSP and HC ↓ ma/pa ratio is in PSP vs. MSA-P and HC ↑ ma/pa ratio in MSA-P vs. HC |
md | Se 60 (PSP vs. MSA-P and HC) Sp 95 (vs. MSA-P and HC) AUC = 0.81 Se 60 (PSP vs. MSA-P) Sp 86 (PSP vs. MSA-P) AUC = 0.62 (PSP vs. MSA-P) |
ma | Se 100 (PSP vs. MSA-P and HC) Sp 90 (PSP vs. MSA-P and HC) AUC = 0.99 Se 87 (PSP vs. MSA-P) Sp 100 (PSP vs. MSA-P) AUC = 0.97 |
||||
pa | Se 73 (PSP vs. MSA-P and HC) Sp 62 (PSP vs. MSA-P and HC) AUC = 0.54 Se 100 (PSP vs. MSA-P) Sp 86 (PSP vs. MSA-P) AUC = 0.96 |
||||
ma/pa ratio | Se 87 (PSP vs. MSA-P and HC) Sp 100 (PSP vs. MSA-P and HC) AUC = 0.96 Se 100 (PSP vs. MSA-P) Sp 100 (PSP vs. MSA-P) AUC = 1.00 |
||||
Midbrain volume | Se 87 (PSP vs. MSA-P and HC) Sp 76 (PSP vs. MSA-P and HC) AUC = 0.83 Se 87 (PSP vs. MSA-P) Sp 71 (PSP vs. MSA-P) AUC = 0.77 |
||||
Lee et al. (2013b) | PD 29/PSP 13/MSA-P 15/HC 21 | 3.0 T | ↓ Volume of caudate, putamen, globus pallidus, and thalamus in PSP and MSA-P vs. PD and HC ↓ Volume of globus pallidus in PSP vs. MSA-P ↓ Volume of putamen in MSA-P vs. PSP ↑ R2* in the putamen in MSA-P vs. PD and HC ↑ R2* in globus pallidus and caudate in PSP vs. PD and HC ↑ R2* in caudate nucleus in PSP vs. MSA-P |
Putaminal volume | AUC = 0.83 (MSA-P vs. PD and PSP) |
Volume of globus pallidus | AUC = 0.86 (PSP vs. PD and MSA-P) | ||||
Baudrexel et al. (2014) | PD 13/PSP 8/MSA-P 11/HC 6 | 3.0 T | ↓ Putaminal volume in MSA-P vs. PD, PSP, and HC | Putaminal volume | Se 54.5 (MSA-P) Sp 100 (vs. other groups) AUC = 0.84 |
Zanigni et al. (2016) | PSP-RS 23/PD 42 | 1.5 T | ↑ Sagittal MCPd/coronal SCPd ratio, pa/maratio, and MRPI in PSP-RS vs. PD ↓ Sagittal MCPd, coronal SCPd, pa, and ma in PSP-RS vs. PD ↑ DTI MD in SCP, thalamus, putamen, globus pallidus, parieto-occipital WM, pre-frontal WM, right brain emisphere, left brain hemisphere, posterior fossa, brainstem, and in cerebellar hemispheres in PSP-RS vs. PD ↓ DTI FA in SCP, midbrain, parieto-occipital WM, pre-frontal WM, right brain hemisphere, left brain hemisphere, posterior fossa, and in brainstem in PSP-RS vs. PD ↓ Volume of brainstem, globus pallidus, putamen and thalamus in PSP-RS vs. PD ↑ Volume of lateral ventricles in PSP-RS vs. PD |
ma | Se 96 (PSP-RS) Sp 98 AUC = 0.99 |
pa/ma-ratio | Se 96 (PSP-RS) Sp 90 AUC = 0.97 |
||||
MRPI | Se 87 (PSP-RS) Sp 93 AUC = 0.95 |
||||
Coronal SCPd | Se 81 (PSP-RS) Sp 74 AUC = 0.84 |
||||
Pons area | Se 87 (PSP-RS) Sp 74 AUC = 0.82 |
||||
MD SCP | Se 70 (PSP-RS) Sp 98 AUC = 0.88 |
||||
MD pre-frontal WM | Se 90 (PSP-RS) Sp 69 AUC = 0.86 |
||||
MD thalamus | Se 70 (PSP-RS) Sp 86 AUC = 0.84 |
||||
MD putamen | Se 80 (PSP-RS) Sp 71 AUC = 0.82 |
||||
MD posterior fossa | Se 80 (PSP-RS) Sp 83 AUC = 0.90 |
||||
MD cerebellar hemispheres | Se 80 (PSP-RS) Sp 74 AUC = 0.86 |
||||
MD right brain hemisphere | Se 75 (PSP-RS) Sp 90 AUC = 0.88 |
||||
MD left brain hemisphere | Se 65 (PSP-RS) Sp 95 AUC = 0.87 |
||||
MD brainstem | Se 85 (PSP-RS) Sp 67 AUC = 0.80 |
||||
FA SCP | Se 75 (PSP-RS) Sp 80 AUC = 0.82 |
||||
FA parieto-occipital WM | Se 75 (PSP-RS) Sp 80 AUC = 0.82 |
||||
FA right brain hemisphere | Se 75 (PSP-RS) Sp 90 AUC = 0.88 |
||||
FA left brain hemisphere | Se 65 (PSP-RS) Sp 95 AUC = 0.87 |
||||
FA posterior fossa | Se 83 (PSP-RS) Sp 75 AUC = 0.80 |
||||
Volume thalamus | Se 73 (PSP-RS) Sp 90 AUC = 0.83 |
||||
Volume putamen | Se 93 (PSP-RS) Sp 70 AUC = 0.83 |
||||
Volume globus pallidus | Se 93 (PSP-RS) Sp 60 AUC = 0.81 |
||||
Oba et al. (2005) | PSP 21/MSA-P 25/PD 23/HC 31 | 1.5 T | ↓ ma in PSP vs. PD and MSA-P ↓ pa in MSA-p vs. PD and PSP ↓ In ma/pa-ratio in PSP vs. PD and MSA-P |
ma | Se 100 (PSP) Sp 91 (PSP vs. non-PSP) |
ma/pa-ratio | Se 100 (PSP) Sp 100 (PSP vs. non-PSP) |
||||
Gama et al. (2010) | PSP 20/MSA-P 8/MSA-C 11/PD 21/ | 1.5 T | ↓ ma in PSP and MSA-P vs. PD, in PSP vs. MSA-C and MSA-P, and in MSA-P vs. MSA-C ↓ pa in PSP, MSA-P, and MSA-C vs. PD, and in MSA-C and MSA-P vs. PSP ↓ MCPd in PSP, MSA-C, and MSA-P vs. PD, and in MSA-C vs. PSP ↓ SCPd in PSP and MSA-C vs. PD, and in PSP vs. MSA-C and MSA-P |
ma | Se 95 (PSP)b
Sp 97 (PSP vs. other groups) |
SCPd | Se 80 (PSP) Sp 100 (vs. other groups) |
||||
Quattrone et al. (2008) | MSA-P 19/PD 108/PSP 33/HC 50 | 1.5 T | ↓ ma and SCPd in PSP compared to PD, MSA-P, and HC with some overlap of values between groups ↑ pa/ma and MCPd/SCPd ratios in PSP compared to PD, MSA-P, and HC with some overlap of values between groups ↑ MRPI in PSP compared to PD, MSA-P, and HC without any overlaps values among groups |
pa/ma ratio | Se 95 (PSP)b
Sp 97 (vs. PD, MSA-P, and HC) |
MCPd/SCPdratio | Se 90 (PSP)b
Sp 94 (vs. PD, MSA-P, and HC) |
||||
MRPI | Se 100 (PSP)b
Sp 100 (vs. PD, MSA-P, and HC) |
||||
Hussl et al. (2010) | MSA-P 26/PSP 22/PD 75 | 1.5 T | ↓ ma/pa-ratio and ↑ MRPI values in PSP compared to MSA-P, PD, and HC | ma/pa ratio | Se 64 (PSP)b
Sp 92 (vs. non-PSP), 95 (vs. PD), 85 (vs. MSA-P) |
MRPI | Se 82 (PSP)b
Sp 80 (vs. non-PSP), 76 (vs. PD), 92 (vs. MSA-P) |
||||
Longoni et al. (2011) | PSP-RS 10/ PSP-P 10/ PD 25/HC 24 | 1.5 T | ↑ pa/ma ratio in PSP-RS and PSP-P vs. PD ↑ MRPI in PSP-RS and PSP-P vs. PD |
pa/ma ratio | Se 90 (PSP-RS vs. PD) Sp 96 (PSP-RS vs. PD) Se 60 (PSP-P vs. PD) Sp 96 (PSP-P vs. PD) |
MRPI | Se 100 (PSP-RS vs. PD) Sp 92 (PSP-RS vs. PD) Se 70 (PSP-P vs. PD) Sp 68 (PSP-P vs. PD) |
||||
Morelli et al. (2011a) | 81 with clinically uncertain parkinsonism (of which n = 15 developed PSP and n = 11 patients developed MSA) | 1.5 T | ↑ MRPI in clinically uncertain parkinsonism in those patients developing PSP at follow-up compared to the other patients MRPI showed a higher accuracy in predicting PSP (92.9%) than clinical features |
MRPI | Se 100 (PSP) Sp 90(PD and MSA) |
Nigro et al. (2016) | PSP 88/PD 234/HC 117 | 1.5 T | ↑ MRPI in PSP vs. PD and controls No statistical differences between automated and manual MRPI values in all groups |
Automated MRPI | Se 93 (PSP) Sp 97 (vs. PD), 94 (vs. HC) |
Manual MRPI | Se 90 (PSP) Sp 100 (vs. PD), 94 (vs. HC) |
||||
3.0 T | Automated MRPI | Se 97 (PSP) Sp 97 (vs. PD), 97 (vs. HC) |
|||
Manual MRPI | Se 100 (PSP) Sp 100 (vs. PD) 100 (vs. HC) |
||||
Mangesius et al. (2017) (manuscript in preparation) | 81 clinically uncertain parkinsonism (including n = 15 who developed PSP and n = 11 who developed MSA) | 1.5 T | md c, ma, ma/pa-ratio, md/pd-ratioc and MRPI showed high overall diagnostic accuracy and specificity (over 80%) in distinguishing PSP from non-PSP neurodegenerative parkinsonism | md | Se 89 (PSP) Sp 91 (vs. other groups), 91 (vs. PD), 92 (vs. MSA) |
ma | Se 68 (PSP) Sp 87 (vs. other groups), 88 (vs. PD), 85 (vs. MSA) |
||||
md/pd-ratio | Se 87 (PSP) Sp 94 (vs. other groups), 94 (vs. PD), 96 (vs. MSA) |
||||
ma/pa-ratio | Se 89 (PSP) Sp 85 (vs. other groups), 82 (vs. PD), 95 (vs. MSA) |
||||
MRPI | Se 87 (PSP) Sp 86 (vs. other groups), 82 (vs. PD), 100 (vs. MSA) |
||||
Nicoletti et al. (2006a) | MSA 16 (MSA-P 13, MSA-C 3)/PD 26/HC 14 | 1.5 T | ↓ Average MCPd in MSA compared to PD and HC using T1-weighted sequences | MCPd | Se 100 (MSA) 100 (vs. PD and HC) |
Massey et al. (2013) | PSP 21/PD 10/MSA 10/HC 21. | 3.0 T | ↓ md c and reduced md/pd-ratioc in PSP compared to MSA-P, PD, and HC | md | Se 90 (PSP) Sp 100 (vs. PD, MSA. HC) |
md/pd-ratio | Se 86 (PSP) Sp 100 (vs. PD, MSA. HC) |
||||
Kim et al. (2015) | PD 82/PSP 29 | 3.0 T | md
d and ma/pa ratio discriminated PSP from PD with similar discriminatory power MRPI showed lower discriminatory power |
md | Se 86 (PSP) Sp 54 AUC = 0.76 |
ma/pa ratio (Cosottini method) (Cosottini et al. 2007) | Se 62 (PSP) Sp 76 AUC = 0.75 |
||||
ma/pa ratio (Oba method) (Oba et al. 2005) | Se 72 (PSP) Sp 64 AUC = 0.75 |
||||
MRPI | Se 93 (PSP-RS) Sp 43 AUC = 0.69 |
||||
Moller et al. (2017) | PD 204/PSP 106/MSA-C 21/MSA-P 60/HC 73 | 1.5 and 3.0 T | ↓ ma in PSP vs. all other groups ↓ pa in MSA-C, MSA-P, and PSP vs. PD and HC. ↓ ma/pa in PSP vs. all other groups ↑ ma/pa in MSA-C and MSA-P vs. PD and PSP |
ma | AUC = 0.90 (PSP vs. PD) Se 75, Sp 82, AUC = 0.85 (PSP vs. MSA-P) |
ma/pa | Se 76, Sp 80, AUC = 0.84 (PSP vs. PD) Se 76, Sp 80, AUC = 0.89 (PSP vs. MSA-P) |
||||
MRPI | Se 64, Sp 64, AUC = 0.75 (PSP vs. PD) Se 73, Sp 60, AUC = 0.80 (PSP vs. MSA-P) |
||||
Automated methods for quantitative MRI analysis | |||||
Huppertz et al. (2016) | PD 204, PSP 106, MSA-C 21, MSA-P 60 | 1.5 and 3.0 T | Fully automated brain volumetry combined with SVM classification allowed for automated differentiation on single-patient level Volume changes of midbrain, basal ganglia, and cerebellar peduncles had the largest relevance for classification |
Atlas-based voxel-based volumetry combined with SVM classification | Classifications between the groups resulted in balanced diagnostic accuracies ≥80% |
Scherfler et al. (2016) | PSP 30/MSA 40/PD 40 of whom 40 presented with a clinically uncertain parkinsonism Data were split into a training (n = 72) and a test set (n = 38) | 1.5 T | Volume segmentation of subcortical brain regions followed by a machine-learning method-derived classification algorithm (i.e. C4.5 decision tree algorithm) Most discriminative regions include the volume of the midbrain, followed by cerebellar GM and putamen Diagnostic accuracy of the fully automated method for quantitative MRI analysis was 97% for the separation of PD vs. MSA or PSP, by contrast to the clinical diagnostic accuracy of 63% based on validated clinical consensus criteria at the time of MRI |
Midbrain, putaminal and cerebellar GM volume | Se 90 (PSP), 100 (MSA), 100 (PD) Sp 100 |
APD atypical parkinsonian disorders, Se sensitivity, Sp specificity, AUC area under the curve; ↑ significant higher, ↓ significant lower, T tesla, MSA multiple system atrophy, MSA-P parkinsonian variant of MSA, MSA-C cerebellar variant of MSA, PD Parkinson’s disease, PSP progressive supranuclear palsy, HC healthy controls, MRI magnetic resonance imaging, VBM voxel-based morphometry, CC corpus callosum, WM white matter, GM grey matter, MCP middle cerebellar peduncle, SCP superior cerebellar peduncle, MRPI magnetic resonance parkinsonism index, m d midbrain diameter, m a midbrain area, p d pontine basis diameter, p a pontine area, SCP d superior cerebellar peduncle diameter, MCP d middle cerebellar peduncle diameter, m d /p d -ratio md to pd ratio, m a /p a -ratio ma to pa-ratio, p a /m a ratio pa to ma ratio, MCP d /SCP d MCPd to SCPd ratio, TIV total intracranial volume, SVM support vector machine, R2* T2* relaxation rate
aNo PD patient was classified as having MSA-P or vice versa; however, three of the PD patients were classified as having MSA-C or PSP; discrimination of patients with MSA from PSP was poor
bDiagnostic accuracy values for planimetric measurements of regional brain structures are highest in PSP; therefore, sensitivity values were primarily given for PSP
cThese diameters were obtained by placing elliptical regions of interest in the midbrain and pontine basis in the midsagittal slice, and obtaining the maximal measurement perpendicular to the major axis of the ellipse
dAs obtained at the mid-mammillary-body level